ConductScience.org, home

Paper17276366

Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.

Kogelnik AM and 5 others. J Clin Virol, 2006. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. Papers, record 17276366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17276366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.
PubMed
Journal
J Clin Virol
PubMed
Year
2006
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
1.4
iCite
Revised in PubMed
2018-12-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kogelnik AMAndreas M
2Loomis KKristin
3Hoegh-Petersen MMette
4Rosso FFernando
5Hischier CCourtney
6Montoya JGJose G

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Central Nervous System DiseasesMajor topic
Epstein-Barr Virus InfectionsMajor topic
Fatigue Syndrome, ChronicMajor topic
GanciclovirMajor topic
Roseolovirus InfectionsMajor topic
Administration, Oral
Adult
Antibodies, Viral
Antiviral Agents
Female
Herpesvirus 4, Human
Herpesvirus 6, Human
Humans
Immunoglobulin G
Male
Middle Aged
Valganciclovir

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
1 F37 LM008480-01NLM NIH HHSUnited StatesF37LM008480PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42797874High Frequency of HHV-7 Reactivation in Neurological and Neuropsychiatric Long COVID: A Retrospective Observational Study.Viruses2026https://conductscience.org/library/papers/42797874PubMed
41472292Does Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Represent a Poly-Herpesvirus Post-Virus Infectious Disease?Viruses2025https://conductscience.org/library/papers/41472292PubMed
40076522Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Aetiology and Potential Treatments.Int J Mol Sci2025https://conductscience.org/library/papers/40076522PubMed
39326415Mechanisms of long COVID and the path toward therapeutics.Cell2024https://conductscience.org/library/papers/39326415PubMed
39201991Long COVID Is Not a Functional Neurologic Disorder.J Pers Med2024https://conductscience.org/library/papers/39201991PubMed
38361801Insights into the interplay between Epstein-Barr virus (EBV) and multiple sclerosis (MS): A state-of-the-art review and implications for vaccine development.Health Sci Rep2024https://conductscience.org/library/papers/38361801PubMed
38256459Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives.J Clin Med2024https://conductscience.org/library/papers/38256459PubMed
37718435Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID?J Transl Med2023https://conductscience.org/library/papers/37718435PubMed
36969241Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.Front Immunol2023https://conductscience.org/library/papers/36969241PubMed
36101642Back to the Future: The Role of Infections in Psychopathology. Focus on OCD.Clin Neuropsychiatry2022https://conductscience.org/library/papers/36101642PubMed
35606640Therapeutic Implications of the Microbial Hypothesis of Mental Illness.Curr Top Behav Neurosci2023https://conductscience.org/library/papers/35606640PubMed
34026797Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Front Med (Lausanne)2021https://conductscience.org/library/papers/34026797PubMed
32664492Low Vitamin D States Observed in U.S. Marines and Navy Sailors with Early Multi-Symptom Illness.Biomolecules2020https://conductscience.org/library/papers/32664492PubMed
31911410Low-dose naltrexone as a treatment for chronic fatigue syndrome.BMJ Case Rep2020https://conductscience.org/library/papers/31911410PubMed
31807568Efficacy and safety of Sijunzi Decoction for chronic fatigue syndrome with spleen deficiency pattern: study protocol for a randomized, double-blind, placebo-controlled trial.Ann Transl Med2019https://conductscience.org/library/papers/31807568PubMed
30871727Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary.Clin Ther2019https://conductscience.org/library/papers/30871727PubMed
28303641Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.J Med Virol2017https://conductscience.org/library/papers/28303641PubMed
28036046Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease.Pathogens2016https://conductscience.org/library/papers/28036046PubMed
25746727Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial.PLoS One2015https://conductscience.org/library/papers/25746727PubMed
25462447The development of new therapies for human herpesvirus 6.Curr Opin Virol2014https://conductscience.org/library/papers/25462447PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17276366

GET https://conductscience.org/api/papers/v1/17276366/cited_by?page=2